Humacyte, Inc. (HUMA) Operating cash flow 2020–2025
Humacyte, Inc. (HUMA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$105.0MFY2025 · since FY2020: -$55.6M → -$105.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.0M | -7.1% |
| FY2024 | -$98.1M | -33.9% |
| FY2023 | -$73.3M | -3.1% |
| FY2022 | -$71.1M | +12.4% |
| FY2021 | -$81.2M | -46.1% |
| FY2020 | -$55.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice